Clinical Trial Update: Thalidomide in Pediatric Inflammatory Bowel Diseases. [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial of thalidomide for inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: IRCCS Burlo Garofolo | Conditions: Inflammatory Bowel Diseases, Crohn's Disease | Phase 3 | Status: COMPLETED